1H22 sales volumes were strong and EBITDA of $6.0M ahead of our expectations. COVID-related issues present near-term uncertainty and we build conservatism into forecast on-premise sales and venue performance, as well as per litre costs for the 2H. The outlook for 2H22 will become clearer by this quarter end and we remain upbeat longer term.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists. If you would like to access our research please contact us to create an account.